Skip to main content
. 2018 Aug 22;10(2):408–417. doi: 10.1111/jdi.12900

Figure 2.

Figure 2

Cumulative incidence of nausea/vomiting caused by glucagon‐like peptide‐1 receptor agonists by sex and retinopathy in type 2 diabetes patients without proton pump inhibitors (PPIs) or histamine‐2 receptor antagonists (H2RAs) treatment. The cumulative incidence of nausea/vomiting was determined using the Fine–Gray method. The P‐value was determined using Gray's test.